MEACOR
PrivateLast Round
Series A
May 14, 2024
Total Funding Raised
$15.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
MEACOR operates in Healthcare & Life Sciences and is based in Irvine, California. Its latest recorded funding round was a Series A round in May 2024.
MEACOR is a healthtech company that develops a catheter-based medical device designed to repair the mitral and tricuspid valves.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MEACOR Comparables
Compare MEACOR with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Valcare Medical | 89% | |
| Micro Interventional Devices, Inc. | 87% | |
| MVRx, Inc. | 85% |
For institutional investors. Book with your work email.
MEACOR Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 14, 2024 | ||||
| Accelerator | Jun 7, 2022 | ||||
| Seed | Jan 8, 2018 | ||||
| Seed | Jun 28, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MEACOR Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Berytech | Seed |
| IM Capital | Seed, Series A |
| MedTech Innovator | Accelerator, Series A |
| IM Fndng | Series A |
| Middle East Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 18, 2026
Grew 50% QoQ, from 6 to 9 employees.
- Sep 12, 2026
Monthly visitors grew 354% MoM, reaching 2K.
For institutional investors. Book with your work email.
MEACOR Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MEACOR's valuation, stock price, and market status.
Is MEACOR a public or private company?
MEACOR is a private company.
What is the current stock price of MEACOR?
MEACOR is a private company, so its shares have no public market price. Caplight tracks MEACOR's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MEACOR worth (valuation)?
Valuation information for MEACOR is not publicly available.
Can I buy MEACOR stock?
MEACOR shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MEACOR's last funding round?
MEACOR's most recent funding round was Series A on May 14, 2024.
Who are the main investors in MEACOR?
Key investors in MEACOR include Berytech, IM Capital, MedTech Innovator, IM Fndng, Middle East Venture Partners.
Will MEACOR IPO soon?
No public IPO plans have been announced for MEACOR.
How can I track MEACOR secondary market activity?
Caplight tracks bids, offers, and trades in MEACOR's shares on secondary markets.